Abstract
Background and aim COVID-19 can be presented with various gastrointestinal symptoms. Shortly after the pandemic outbreak several machine learning algorithms have been implemented to assess new diagnostic and therapeutic methods for this disease. Aim of this study is to assess gastrointestinal and liver related predictive factors for SARS-CoV-2 associated risk of hospitalization.
Methods Data collection was based on questionnaire from the COVID-19 outpatient test center and from the emergency department at the University hospital in combination with data from internal hospital information system and from the mobile application used for telemedicine follow-up of patients. For statistical analysis SARS-CoV-2 negative patients were considered as controls to three different SARS-CoV-2 positive patient groups (divided based on severity of the disease).
Results Total of 710 patients were enrolled in the study. Presence of diarrhea and nausea was significantly higher in emergency department group than in the COVID-19 outpatient test center. Among liver enzymes only aspartate transaminase (AST) has been significantly elevated in the hospitalized group compared to patients discharged home. Based on random forest algorithm, AST has been identified as the most important predictor followed by age or diabetes mellitus. Diarrhea and bloating have also predictive importance although much lower than AST.
Conclusion SARS-CoV-2 positivity is connected with isolated AST elevation and the level is linked with the severity of the disease. Furthermore, using machine learning random forest algorithm, we have identified elevated AST as the most important predictor for COVID-19 related hospitalizations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This publication has been produced with the support of: The Integrated Infrastructure Operational Program for the project: Research and develop-ment of telemedicine solutions to support the fight against pandemic diseases induced Covide-19 and reducing its negative consequences by monitoring the health status of people in order to elimi-nate the risk of infection in at-risk populations, ITMS: 313011ASY8, co-financed by the European Regional Development Fund. The Integrated Infrastructure Operational Program for the project: New possibilities for la-boratory diagnostics and massive screening of SARS-Cov-2 and identification of mechanisms of virus behavior in human body, ITMS: 313011AUA4, co-financed by the European Regional De-velopment Fund. By Ministry of Health of the Slovak Republic under the project registration number 2019/44-UKMT-7.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethical committee of the University hospital in Martin, decision number: 14/2021.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- PCR
- (polymerase chain reaction)
- ALT
- (Alanin transaminase)
- AST
- (aspartate transaminase)
- ICU
- (intensive care unit)
- ED
- (emergency department)
- ROC
- (receiver operating characteristic)
- PCA
- (Principal component analysis)
- RF
- (random forest)
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos